Your browser doesn't support javascript.
loading
Dry eye symptoms and health-related quality of life among Chinese individuals: a national-based study.
Kai, Jia-Yan; Wu, Yi-Bo; Shi, Bing; Li, Dan-Lin; Dong, Xing-Xuan; Wang, Pei; Pan, Chen-Wei.
Afiliación
  • Kai JY; School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China.
  • Wu YB; School of Public Health, Peking University, Beijing, China.
  • Shi B; Department of Public Health, Suzhou Industrial Park Center for Disease Control and Prevention, Suzhou, China.
  • Li DL; School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China.
  • Dong XX; School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China.
  • Wang P; School of Public Health, Fudan University, Shanghai, China pcwonly@gmail.com wang_p@fudan.edu.cn.
  • Pan CW; Key Lab of Health Technology Assessment, National Health Commission of the People's Republic of China (Fudan University), Shanghai, China.
Br J Ophthalmol ; 2024 Mar 12.
Article en En | MEDLINE | ID: mdl-38471750
ABSTRACT

AIMS:

To assess the impact of dry eye symptoms (DESs) on health-related quality of life (HRQOL) among Chinese residents.

METHODS:

A total of 21 916 participants were involved in this nationwide cross-sectional study. All of them completed the Ocular Surface Disease Index-6 and the five-level European Quality of Life 5-Dimensional (EQ-5D) Questionnaire to assess the severity of DES and HRQOL, respectively. Multiple linear regression models were used to explore the associations of DES with EQ-5D health utility score (HUS) and visual analogue scale (VAS) score. We used logistic regression models to assess the relationships between DES and self-reported problems in the EQ-5D dimensions.

RESULTS:

Overall, 43.6% of participants reported DESs. Of them, 2511 (11.5%) were with mild symptoms, 2762 (12.6%) were with moderate symptoms and 4288 (19.6%) were with severe symptoms. Both EQ-5D HUS and VAS score were significantly negatively associated with the severity of DES. The difference in HUS between patients with no symptoms and severe symptoms (0.085) was larger than the minimally clinical important difference for EQ-5D. The loss in HRQOL was greater for patients with severe DES than those just with other comorbidities. Participants with DES had a significantly higher risk of reporting problems in all five EQ-5D dimensions, especially in pain/discomfort and anxiety/depression for patients with mild or moderate symptoms and in mobility, self-care and usual activities for severe patients.

CONCLUSION:

Patients with more severe DES tend to have lower HRQOL. Effective interventions targeted at different HRQOL dimensions should be taken according to the severity of DES.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Br J Ophthalmol Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Br J Ophthalmol Año: 2024 Tipo del documento: Article País de afiliación: China